×
ADVERTISEMENT

mesothelioma

FDA Approves Keytruda With Chemo for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

The FDA has approved pembrolizumab (Keytruda, Merck) with pemetrexed and platinum-based chemotherapy as first-line ...

SEPTEMBER 18, 2024

FDA Grants Mesothelioma Indication to Opdivo Plus Yervoy

The FDA approved a new indication for the combination of nivolumab (Opdivo) plus ipilimumab (Yervoy),  both ...

OCTOBER 5, 2020

Modest Results for Checkpoint Agents in Mesothelioma

Chicago— Two trials presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO) ...

SEPTEMBER 13, 2016

Load more